Chung Kevin 4
4 · SeaStar Medical Holding Corp · Filed Feb 10, 2026
Research Summary
AI-generated summary of this filing
SeaStar Medical (ICU) CMO Kevin Chung Receives RSU Award
What Happened
Kevin Chung, Chief Medical Officer of SeaStar Medical Holding Corp (ticker: ICU), was granted 15,000 restricted stock units (RSUs) on February 6, 2026. The award is recorded at $0.00 per share (Form 4 acquisition code "A"), meaning this is a compensation grant rather than an open‑market purchase or sale.
Key Details
- Transaction date: 2026-02-06; Form 4 filed: 2026-02-10 (filed within the 2-business-day window).
- Award: 15,000 RSUs; acquisition price shown as $0.00.
- Vesting: RSUs vest in equal installments on the first, second and third anniversaries of February 6, 2026 (per footnote).
- Shares owned after the transaction: not disclosed in the provided filing.
- No 10b5-1 plan, tax‑withholding, or sale/disposition noted in this transaction.
Context
RSUs are a common form of executive compensation and vest over time, aligning executives’ interests with long‑term share performance. Because this is a grant (compensation) rather than a purchase or sale, it does not by itself signal a near‑term trading opinion by the insider — instead it reflects compensation/retention policy.
Insider Transaction Report
- Award
Common Stock, par value $0.0001
[F1]2026-02-06+15,000→ 20,819 total
Footnotes (1)
- [F1]Represents an RSU award. The RSU award vests in equal installments on the first, second and third anniversaries of February 6, 2026